Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis

Genetic Background Modifies the Effects of Type 2 Cannabinoid Receptor Deficiency on Bone Mass and Bone Turnover

(2013) Antonia Sophocleous et al.   CALCIFIED TISSUE INTERNATIONAL

Cannabinoids: A new hope for breast cancer therapy?

(2012) María M. Caffarel et al.   CANCER TREATMENT REVIEWS

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold

(2012) Clementina Manera et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists

(2012) Alysia N Lozano-Ondoua et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro

(2011) LS Whyte et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation

(2011) Antonia Sophocleous et al.   ENDOCRINOLOGY

Spinal and peripheral analgesic effects of the CB2cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain

(2010) V Curto-Reyes et al.   BRITISH JOURNAL OF PHARMACOLOGY

Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo

(2010) Aymen I. Idris et al.   FASEB JOURNAL

A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss

(2010) Alysia N. Lozano-Ondoua et al.   LIFE SCIENCES

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1

(2009) Robert Ramer et al.   BIOCHEMICAL PHARMACOLOGY

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

(2009) N Olea-Herrero et al.   BRITISH JOURNAL OF CANCER

Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells

(2009) Aymen I. Idris et al.   Cell Metabolism

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

(2009) L. S. Whyte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

β2-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms

(2008) Sarah J. Aitken et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro

(2008) Aymen I. Idris et al.   CALCIFIED TISSUE INTERNATIONAL

Cannabinoids for Cancer Treatment: Progress and Promise

(2008) S. Sarfaraz et al.   CANCER RESEARCH

Endocannabinoids in endocrine and related tumours

(2008) M. Bifulco et al.   ENDOCRINE-RELATED CANCER

Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor

(2008) Aymen I. Idris et al.   ENDOCRINOLOGY

JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells

(2008) M M Caffarel et al.   ONCOGENE